SARS-CoV-2-IN-48
SARS-CoV-2-IN-48 (compound 19) is a SARS-CoV-2 inhibitor with an IC50 of 2.7 μM for Omicron BA.1. SARS-CoV-2-IN-48 shows antiviral activities[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-48.html
Solubility
10 mM in DMSO
Smiles
OC1=C(O)C=C(/C=C/C(O[C@@H](C(NC2=CC=CC(CC)=C2)=O)CC3=CC(O)=C(O)C=C3)=O)C=C1
Molecular Formula
C26H25NO7
Molecular Weight
463.48
References & Citations
[1]Osbert Chou, et al. Isolation of Anti-SARS-CoV-2 Natural Products Extracted from Mentha canadensis and the Semi-synthesis of Antiviral Derivatives. J Nat Prod. 2023 Jun 23;86 (6) :1428-1436.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1339358-01 0.02 mg (E-Coli)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details 
MBS1339358-02 0.1 mg (E-Coli)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details 
MBS1339358-03 0.02 mg (Yeast)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details 
MBS1339358-04 0.1 mg (Yeast)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details MBS1339358-05 0.02 mg (Baculovirus)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details MBS1339358-06 0.02 mg (Mammalian-Cell)
Recombinant Hahella chejuensis Oligoribonuclease (orn)
Ask
View Details